mybacs

Central African Republic
Bayanga, Sangha-Mbaéré, Central African Republic, 6300

Company profile

mybacs company profile

mybacs is a research-driven DTC company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
6300
Country code
CF
Continent
Africa

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$7.7M
Last funding
Series A / $5.9M / 2023-10-19
Last equity funding
Series A / $5.9M
Investors
7
Lead investors
2
Founders
2
Articles
5

Founders and investors

Founders

Carl-Philipp von PolheimSebastian Wahl

Lead investors

Global Founders CapitalnaturalX Health Ventures

Investors

G-FUNDGlobal Founders CapitalJoyance PartnersnaturalX Health VenturesSocial Starts